From the endocrine system: hypoglycemia, hypoglycemic coma.
From the nervous system: dizziness, headache, drowsiness.
From the skin: rash on the skin and mucous membranes, itching, hives, eczema, photosensitivity.
From the hematopoiesis: oppression of bone marrow hematopoiesis (anemia, including aplastic and hemolytic, pancytopenia, leukopenia, agranulocytosis, thrombocytopenia).
From the digestive system: nausea, vomiting, diarrhea or constipation, flatulence, cholestatic jaundice, hepatic insufficiency, hepatitis, acute porphyria, hepatic porphyria.
From the sense organs: blurred vision, visual impairment.
Laboratory indicators: increased activity of aspartate aminotransferase (ACT), lactate dehydrogenase (LDH), alkaline phosphatase (FA), an increase in residual urea nitrogen in the blood plasma, hypercreatininaemia.
Other: weight gain, myalgia, convulsions, hyponatremia, disulfiramopogood reactions.
From the gastrointestinal tract: nausea, vomiting, constipation, diarrhea, epigastric pain, hepatitis.
From the skin: urticaria rash, itchy skin, multiforme exudative erythema.
From the hematopoiesis: anemia, aplastic and hemolytic anemia, pancytopenia, leukopenia, agranulocytosis, eosinophilia, thrombocytopenia.
Other: Perhaps the development of hyponatremia and the violation of the secretion of antidiuretic hormone.